In Bengaluru’s fast-growing deep-tech corridor, Sophrosyne Technologies is quietly shaping what could be the next leap in wearable health innovation. The semiconductor startup has just raised $2 million in seed funding, led by Bluehill.VC — a name that carries weight in India’s deep-tech investing circles.
For Sophrosyne, the milestone comes on the heels of clearing a rigorous technical diligence process and securing the MeitY DLI grant worth $1.2 million, a validation reserved for only a handful of high-potential semiconductor ventures in the country.
Co-founders Manish Srivastava and Jatin Gupta, who started the company in 2022, have been working on a problem that has long limited the health-tech and wearable ecosystem: fragmented sensing architecture. Their answer is a unified, multi-vital biosensing SoC that can measure ECG, PPG, respiration, temperature, and related vitals — all with high precision and exceptionally low energy draw.
“We’re consolidating what typically requires multiple chips into one compact architecture,” Manish explains. “That means wearables can get smaller, more efficient, and far more capable of delivering continuous health insights.”
The fresh capital will help the company move from prototype silicon to full-scale development, deepen its silicon and firmware capabilities, and expand early deployments across India and global markets.
Manish credits the quality of mentorship as much as the money:
“Having a deep-tech investor like Bluehill.VC, backed by leaders such as Vinod Dham, Manu Iyer and Sridhar Parthasarathi, gives us access to world-class semiconductor guidance that few startups can tap into. Beyond capital, they bring discipline, clarity, and the ability to help us scale this technology globally.”
With a Rs 350 crore fund focused on engineering-first innovation across sectors like semiconductors, EVs, energy, robotics, and industrial IoT, Bluehill.VC’s thesis aligns closely with the kind of IP-first work Sophrosyne is building.
As India pushes toward semiconductor self-reliance, startups like Sophrosyne are beginning to define what the next decade of homegrown deep-tech could look like: specialised, globally competitive, and built on strong technical roots.
-By Muskan Dengra
